Akgonul Rifat Kerim 4

4 · PEGASYSTEMS INC · Filed Mar 3, 2026

Form 4

Period: 2026-03-01

Chief Product Officer

Transactions

Exercise/Conversion
Common stock
2026-03-01+1,174→ 107,068 total
Tax Payment
Common stock
2026-03-01$43.73/sh−407$17,798→ 106,661 total
Exercise/Conversion
Common stock
2026-03-02+462→ 107,123 total
Tax Payment
Common stock
2026-03-02$43.73/sh−161$7,041→ 106,962 total
Sale
Common stock
[F1]
2026-03-02$43.84/sh−7,000$306,905→ 99,962 total
Exercise/Conversion
Restricted Stock Units
[F2][F3]
2026-03-01−1,174→ 4,702 total
Exercise: $0.00From: 2023-03-01Exp: 2027-03-01→ Common stock (1,174 underlying)
Exercise/Conversion
Restricted Stock Units
[F2][F3]
2026-03-02−462→ 0 total
Exercise: $0.00From: 2022-03-02Exp: 2026-03-02→ Common stock (462 underlying)

Footnotes (3)

[F1]Represents the weighted average of sale prices, ranging from $43.84 to $43.86. The individual has provided the Company, and undertakes to provide to the staff of the Security and Exchange Commission or any security holder of the Company, upon request, full information regarding the number of shares sold at each separate price.
[F2]Each restricted stock unit represents the right to receive, following vesting, one share of common stock.
[F3]20% of the restricted stock units vested on the Date Exercisable in Table II, and the remaining 80% vest in equal quarterly installments over the following four years.

Signature

/s/Kathryn Leach, Attorney-in-Fact for Rifat Kerim Akgonul|2026-03-03

Documents

1 file